Bench to Bed

Type 2 Diabetes

A page on conditions in our medical research coverage, part of our health reporting, alongside the 8 reports filed on it so far.

The FDA has approved rebisufligene etisparvovec (Fayuvi) as the first treatment for pediatric patients with...

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

The FDA has approved rebisufligene etisparvovec (Fayuvi) as the first treatment for pediatric patients with mucopolysaccharidosis type IIIA.

2026-09-19
Kura Oncology has spun out a new biotech startup, Caspian Therapeutics, to develop menin inhibitor drugs for diabetes and...

Kura spins out Caspian to test menin inhibitors for diabetes

Kura Oncology has spun out a new biotech startup, Caspian Therapeutics, to develop menin inhibitor drugs for diabetes and cardiometabolic diseases.

2026-09-10
The American Diabetes Association concluded an internal review, stating five members were removed from its June annual...

ADA: Removed Attendees Violated Conduct Code

The American Diabetes Association concluded an internal review, stating five members were removed from its June annual meeting for disruptive conduct.

2026-09-03
The American Diabetes Association denies censoring protest or involving police when expelling five members from its June...

ADA Review Denies Censorship in Expulsions

The American Diabetes Association denies censoring protest or involving police when expelling five members from its June scientific sessions.

2026-09-02
An independent review commissioned by the American Diabetes Association found that attendees were removed from the June...

ADA CEO Releases Independent Review of June Meeting Removals

An independent review commissioned by the American Diabetes Association found that attendees were removed from the June Scientific Sessions for...

2026-09-02
Takeda's orexin-mimicking drug Orzeyful won FDA approval in August for narcolepsy type 1, with experts dubbing the class...

FDA approval ignites orexin drug race

Takeda's orexin-mimicking drug Orzeyful won FDA approval in August for narcolepsy type 1, with experts dubbing the class the 'GLPs of neuroscience'...

2026-08-31
Verily Health, with NVIDIA and the NIH All of Us program, developed a foundation model combining EHR and genomic data

Verily-NIH multimodal AI model boosts Type 2 diabetes risk detection

Verily Health, with NVIDIA and the NIH All of Us program, developed a foundation model combining EHR and genomic data. The model's performance for...

2026-08-31
A retrospective cohort study links alpha-gal syndrome to increased allergic transfusion reactions in type O patients...

Study Warns on Alpha-Gal Syndrome and Blood Transfusion Risks

A retrospective cohort study links alpha-gal syndrome to increased allergic transfusion reactions in type O patients receiving B or AB plasma or...

2026-08-24